Cancer BiologybioRxivPreprint
HLA-G gene editing: a novel therapeutic alternative in cancer immunotherapy
M. B. Palma, D. Tronik-Le Roux, G. Amin…·S. G. Miriuka
This study uses CRISPR/Cas9 to downregulate HLA-G in tumor cell lines, showing enhanced immune response and proposing gene editing as a novel immunotherapy approach.
DOI 10.1101/2021.01.21.427294